What are the Risks Associated with Continuation Vehicles?

While continuation vehicles offer significant strategic benefits, they involve several complex risks and challenges that both General Partners (GPs) and Limited Partners (LPs) must navigate:

• Inherent Conflicts of Interest: The primary risk stems from the GP serving as both the seller (on behalf of the existing fund) and the buyer (as the sponsor of the new continuation vehicle). This dual role can create friction regarding deal terms and asset management.
• Valuation Difficulties: Because these transactions involve inherently illiquid assets, determining a fair market price is challenging. Ensuring the transaction occurs at a fair value requires rigorous third-party valuation work and independent fairness opinions to protect all stakeholders.
• Complex Fee Structures: Investors must scrutinize the impact of management fees, transaction-related costs, and carried interest calculations. There is a risk that these fees could negatively impact net returns if not structured transparently.
• Alignment and Oversight Issues: There are risks regarding whether the GP’s incentives truly align with the LPs. This includes the level of GP co-investment and the independence of the oversight committee or advisory board in mitigating conflicts.
• Regulatory Requirements: All transactions must adhere to FINRA regulatory compliance standards and SEC frameworks. Failure to provide transparent disclosures or follow fair-dealing obligations can lead to regulatory and legal complications.

• Private Equity Continuation Funds: Complete Guide for Investors